US Recall News

United States Recall News Alerts for Recalled Drugs, Food, Products, & Vehicles

MENUMENU
  • Home
  • About
    • Advertise
  • Full Recall News Archive
    • Top Story

      J&J Settles Talc Mesothelioma Settlement

      By Sandra Dalton, Staff Writer On January 6, 2020, Superior Court Judge Stephen Kaus announced that Johnson & Johnsons (J&J) had agreed to … [Read More...]

      YaFiti White Dressers Recalled Due to Risk of Serious Injury or Death from Tip-Over and Entrapment Hazards; Violations of Federal Standard for Clothing Storage Units; Sold on Amazon

      The recalled dressers are unstable if they are not anchored to the wall, posing serious tip-over and entrapment hazards that can result in injuries or … [Read More...]

    • More Safety Articles
    • Federal Preemption of State Product Liability Law
  • Drug Recalls
    • Abilify
    • Benicar
    • Fluoroquinolones
    • Invokana
    • Lipitor
    • Nuplazid
    • Opioids
    • OxyContin
    • Pradaxa
    • Proton Pump Inhibitors (PPIs)
    • Risperdal
    • SSRI
    • Symptoms & Side Effects
    • Taxotere
    • Testosterone
    • Uloric
    • Valsartan
    • Xarelto
    • Zofran
  • Medical Devices
    • 3M Earplug
    • 3T Heater-Cooler System
    • Bair Hugger
    • Bipolar Hip System
    • Essure
    • Hip Replacements
    • Implanon
    • IVC Filters
    • Hernia Mesh
    • Power Morcellators
    • Shoulder Implants
    • Transvaginal Mesh
  • Food Recalls
    • FDA Press Releases
    • USDA Press Releases
  • Auto Recalls
    • Air Bags
    • Ignitions
    • NHTSA Press Releases
    • Off-Road Utility Vehicles
    • Snowmobiles
    • Tires
  • Other Products
    • Asbestos
    • Baby Products
    • Pet Products
    • Roundup
    • Talcum Powder
    • Toy Recalls
You are here: Home / Food Recalls / FDA Press Releases / Baxter to Proceed with Recall of Remaining Heparin Sodium Vial Products (Feb. 28)

Baxter to Proceed with Recall of Remaining Heparin Sodium Vial Products (Feb. 28)

March 17, 2008 By The FDA Leave a Comment

CONTACT: ERIN GARDINER, (847) 948-4210 DEBORAH SPAK, (847) 948-2349

FOR IMMEDIATE RELEASE — DEERFIELD, ILL., FEBRUARY 28, 2008 – BAXTER INTERNATIONAL INC. ANNOUNCED TODAY THAT THE COMPANY IS PROCEEDING WITH THE VOLUNTARY RECALL OF ALL REMAINING LOTS AND DOSES OF ITS HEPARIN SODIUM INJECTION MULTI-DOSE, SINGLE-DOSE VIALS AND HEP-LOCK HEPARIN FLUSH PRODUCTS.

THE COMPANY INITIALLY RECALLED NINE LOTS OF HEPARIN SODIUM INJECTION MULTI-DOSE VIALS ON JANUARY 17, 2008 AS A PRECAUTIONARY MEASURE DUE TO A HIGHER THAN USUAL NUMBER OF REPORTS OF ADVERSE PATIENT REACTIONS INVOLVING THE PRODUCT AND SUSPENDED PRODUCTION EARLIER THIS MONTH.

GIVEN THE WIDESPREAD USE OF THIS BLOOD THINNER AND THE IMPACT A PRODUCT SHORTAGE WOULD HAVE ON OPERATING ROOMS, DIALYSIS CENTERS AND OTHER CRITICAL CARE AREAS, THE FDA AND BAXTER CONCLUDED THAT REMOVING ADDITIONAL LOTS AND DOSES OF BAXTER’S HEPARIN FROM THE MARKET EARLIER WOULD HAVE CREATED MORE RISK TO PATIENTS REQUIRING HEPARIN THERAPY THAN THE INCREASED POTENTIAL FOR EXPERIENCING AN ADVERSE REACTION. ACCORDINGLY, THE FDA AND BAXTER DECIDED NOT TO RECALL ALL BAXTER HEPARIN VIAL PRODUCTS AT THAT TIME. THE FDA HAS NOW CONCLUDED THAT THERE IS SUFFICIENT CAPACITY ON THE PART OF OTHER SUPPLIERS THAT BAXTER’S RECALL WILL NOT JEOPARDIZE ACCESS TO THIS DRUG, AND HAS TOLD BAXTER THAT THE COMPANY CAN NOW PROCEED WITH RECALLING ITS REMAINING HEPARIN SODIUM INJECTION AND HEPARIN FLUSH PRODUCTS.

ALTHOUGH THE VAST MAJORITY OF THE REPORTS OF ADVERSE REACTIONS HAVE BEEN ASSOCIATED WITH THE MULTI-DOSE PRODUCTS, BAXTER IS TAKING THE PRECAUTIONARY STEP OF RECALLING ALL REMAINING HEPARIN SODIUM INJECTION AND HEPARIN FLUSH PRODUCTS THAT ARE CURRENTLY ON THE MARKET. IN ADDITION TO THE PREVIOUSLY RECALLED LOTS OF HEPARIN SODIUM INJECTION 1000 UNITS/ML 10ML AND 30ML MULTI-DOSE VIALS, BAXTER’S RECALL WILL NOW INCLUDE THE REMAINING LOTS OF THOSE PRODUCTS AND HEPARIN SODIUM INJECTION 5000 UNITS/ML 10ML MULTI-DOSE VIALS, HEPARIN SODIUM INJECTION 10,000 UNITS/ML 4ML MULTI-DOSE VIALS, HEPARIN SODIUM INJECTION 1000 USP UNITS/ML, 5000 USP UNITS/ML, AND 10,000 USP UNITS/ML SINGLE-DOSE VIALS, AND ALL HEP-LOCK AND HEP-LOCK U/P, 10 USP UNITS/ML AND 100 USP UNITS/ML VIALS, BOTH PRESERVED AND PRESERVATIVE-FREE.

THIS RECALL DOES NOT INVOLVE BAXTER’S HEPARIN PRE-MIX IV SOLUTIONS IN BAGS: HEPARIN SODIUM IN 5% DEXTROSE INJECTION AND HEPARIN SODIUM IN 0.9% SODIUM CHLORIDE INJECTION.

“WE HAVE ASSURANCE FROM THE U.S. FOOD AND DRUG ADMINISTRATION THAT THERE IS AN ADEQUATE SUPPLY IN THE MARKET TO MEET THE DEMAND FOR THESE CRITICAL AND LIFESAVING DRUGS,” SAID PETER J. ARDUINI, PRESIDENT OF BAXTER’S MEDICATION DELIVERY BUSINESS. “THE SAFETY AND QUALITY OF OUR PRODUCTS IS ALWAYS OUR HIGHEST PRIORITY, AND WE WILL CONTINUE TO COLLABORATE WITH THE FDA AS WE WORK TO DETERMINE THE CAUSE OF THE INCREASED RATE OF ADVERSE REACTIONS AND RESOLVE THIS ISSUE.”

NEARLY ALL REPORTED ADVERSE REACTIONS HAVE OCCURRED IN THREE SPECIFIC AREAS OF PRODUCT USE – RENAL DIALYSIS, INVASIVE CARDIOVASCULAR PROCEDURES AND APHERESIS PROCEDURES. REPORTED ADVERSE PATIENT REACTIONS HAVE INCLUDED: STOMACH PAIN OR DISCOMFORT, NAUSEA, VOMITING, DIARRHEA, DECREASED OR LOW BLOOD PRESSURE, CHEST PAIN, FAST HEART RATE, DIZZINESS, FAINTING, UNRESPONSIVENESS, SHORTNESS OF BREATH, THE FEELING OF A STRONG OR RAPID HEARTBEAT, DRUG INEFFECTIVENESS, BURNING SENSATION, REDNESS OR PALENESS OF SKIN, ABNORMAL SENSATION OF THE SKIN, MOUTH OR LIPS, FLUSHING, INCREASED SWEATING, DECREASED SKIN SENSITIVITY, HEADACHE, FEELING UNWELL, RESTLESSNESS, WATERY EYES, THROAT SWELLING, THIRST, BLEEDING TENDENCIES AND DIFFICULTY OPENING THE MOUTH. SOME OF THESE REACTIONS, PARTICULARLY PROFOUND AND REFRACTORY HYPOTENSION, MAY BE SEVERE OR LIFE-THREATENING.

CUSTOMERS HAVE BEEN INSTRUCTED TO DISCONTINUE USE AND SEGREGATE THE RECALLED PRODUCT FROM THE REST OF THEIR INVENTORY. CUSTOMERS SHOULD THEN CONTACT BAXTER TO ARRANGE FOR RETURN AND REPLACEMENT PRODUCT. CUSTOMERS WITH RECALLED PRODUCT PURCHASED INDIRECTLY SHOULD CONTACT THEIR WHOLESALER OR DISTRIBUTOR FOR RETURN AND REPLACEMENT PRODUCT. CUSTOMERS WITH QUESTIONS MAY CONTACT THE CENTER FOR ONE BAXTER AT 1-800-4-BAXTER (1-800-422-9837). REPRESENTATIVES WILL BE AVAILABLE TWENTY-FOUR HOURS A DAY, SEVEN DAYS A WEEK.

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Related

Filed Under: FDA Press Releases

About The FDA

The Food and Drug Administration (FDA) is an agency within the U.S. Department of Health and Human Services. It consists of the Office of the Commissioner and four directorates overseeing the core functions of the agency: Medical Products and Tobacco, Foods and Veterinary Medicine, Global Regulatory Operations and Policy, and Operations.

Leave a ReplyCancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Facebook
Thomas Roney LLC
Economic Consulting

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

YaFiti White Dressers Recalled Due to Risk of Serious Injury or Death from Tip-Over and Entrapment Hazards; Violations of Federal Standard for Clothing Storage Units; Sold on Amazon

June 17, 2025 By The CPSC

AstroAI Recalls Minifridges Due to Fire and Burn Hazards; Two Fires Resulted in More Than $360,000 in Reported Property Damages

June 17, 2025 By The CPSC

Polaris Recalls Ranger XP Kinetic and Pro XD Kinetic Recreational Off-Highway Vehicles (ROVs) Due to Fire Hazard

June 17, 2025 By The CPSC

Hero Highlight

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

MaxKare Electric Blankets Recalled Due to Burn and Fire Hazards; Manufactured by Yumo and Sold Exclusively on Walmart.com

June 17, 2025 By The CPSC

Weaver Nut Company Inc., Issues Allergy Alert on Undeclared Milk in Chocolate Nonpareils

June 17, 2025 By The FDA

Medtech Products Inc. Issues Nationwide Recall of Little Remedies® Honey Cough Syrup Due to Microbial Contamination

June 17, 2025 By The FDA

Meijer Issues Recall on Frederik’s Dark Chocolate Almonds Due to Presence of Undeclared Cashews

June 13, 2025 By The FDA

Fuentes Farms, LLC Recalls Product Because of Possible Health Risk

June 13, 2025 By The FDA

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Meijer Issues Recall on Frederik’s Dark Chocolate Almonds Due to Presence of Undeclared Cashews

June 13, 2025 By The FDA

Fuentes Farms, LLC Recalls Product Because of Possible Health Risk

June 13, 2025 By The FDA

Turkana Food Inc. Recall Flora Dried Apricots with Undeclared Sulfites on Product Labeling Because of Possible Health Risk

June 12, 2025 By The FDA

Recall News in Your Inbox

Enter your email address to receive automated recall news updates.

Recent Comments

  • Roger McGowan on ABH NATURE’S PRODUCTS, INC, ABH PHARMA, INC., and STOCKNUTRA.COM, INC. Issues Nationwide Recall of All Lots of Dietary Supplement Products
  • Kathryn Moore on FDA Wants Cancer Warning on Breast Implants
  • BRAD on Huge ATV Recall by Polaris – Sportsman and Scrambler
  • Crystal Anderson on Allergan Voluntarily Recalls BIOCELL® Textured Breast Implants and Tissue Expanders
  • Outsourcing Training on The Modern Marketing of Pain
  • SANDRA Collett on Processed Food Preservative Linked to Autism?
  • Eric Karsh on Health Risks of Roundup Go Well Beyond Cancer

Recent Posts

  • YaFiti White Dressers Recalled Due to Risk of Serious Injury or Death from Tip-Over and Entrapment Hazards; Violations of Federal Standard for Clothing Storage Units; Sold on Amazon
  • AstroAI Recalls Minifridges Due to Fire and Burn Hazards; Two Fires Resulted in More Than $360,000 in Reported Property Damages
  • Polaris Recalls Ranger XP Kinetic and Pro XD Kinetic Recreational Off-Highway Vehicles (ROVs) Due to Fire Hazard
  • Crayan Mattresses Recalled Due to Risk of Serious Injury or Death from Fire Hazard; Violation of Federal Standard for Mattress Flammability; Sold Exclusively on Amazon by Crayan
  • TADAKAZU Baby Loungers Recalled Due to Risk of Serious Injury or Death from Suffocation, Fall and Entrapment Hazards; Violations of Federal Standard for Infant Sleep Products; Sold on Amazon
  • MaxKare Electric Blankets Recalled Due to Burn and Fire Hazards; Manufactured by Yumo and Sold Exclusively on Walmart.com
  • Weaver Nut Company Inc., Issues Allergy Alert on Undeclared Milk in Chocolate Nonpareils
  • Medtech Products Inc. Issues Nationwide Recall of Little Remedies® Honey Cough Syrup Due to Microbial Contamination
  • Meijer Issues Recall on Frederik’s Dark Chocolate Almonds Due to Presence of Undeclared Cashews
-- See More Recall News

Disclaimer: The information contained in these topics is not intended nor implied to be a substitute for professional medical or legal advice, it is provided for educational purposes only. Always seek the advice of your physician or other qualified healthcare provider about any questions you may have regarding a medical condition. Nothing contained in these topics is intended to be used for medical diagnosis or treatment.


ATTORNEY ADVERTISING. The information provided on this website is not legal advice. No attorney-client relationship is formed by the use of this site. It is not stated or implied that a lawyer is certified as a specialist in any particular field of law. No results are guaranteed, and prior results do not guarantee a similar outcome. This site is informational, only, not dispositive; it is up to you to decide whether a particular lawyer is right for you. Use of this site is subject to your agreement to these.


Copyright © 2025 Altrumedia · Terms of Service · Log in